Accrued Expenses and Other Current Liabilities

9 Months Ended

Sep. 30, 2020

Payables and Accruals [Abstract]

Accrued Expenses and Other Current Liabilities

Accrued Expenses and Other Current Liabilities

Accrued expenses consisted of the following:

	As of September 30, 2020		As of December 31, 2019
Accrued development milestones	$	7,167	$	12,000
Accrued employee compensation and benefits	19,835		3,521
Accrued clinical trial costs	15,097		16,476
Accrued commercialization and other professional fees	12,244		15,408
Other accrued expenses and current liabilities	71,924		4,697
	$	126,267	$	52,102